A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07670416
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07670416
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07670416. Randomized; double masking; primary purpose treatment. Start 2026-07-03 (actual); primary completion 2028-02-24 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
- Condition
- Obesity
- Condition
- Overweight
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Combination product)
- Enicepatide
- Intervention (Combination product)
- Placebo
- Lead sponsor
- Hoffmann-La Roche
Record details
- Record id
cardio:ct-nct07670416- Content hash
d1976cbab366d8d5f3e90079015cc05a77a1f95767e9d5f494860ab7b55798ef